This protocol is judged by an institutional evaluation board, an impartial team that evaluations any clinical trials involving people. If a review involves a Routine I drug, once the board approves the protocol as ethical, the researchers need to submit an application for an investigational new drug (IND) range in the FDA.“It’s vital that you